http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3214443-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d138e5522d31a8ee9bcb118c0309451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92d71a3e23389a3bca747290fc6464cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acae886d7fc13db991247cb273eb71bd |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96494 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-24017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
filingDate | 2015-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_221c9293e99fc97cb6ea4bb2329fab2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9500cfd5d2c7728b0b965efe045ea88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ab4b2c6a95f7743716290feeef01a32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38cb55a1bd532a75ae4db915d4b55df5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e61a0dc0dfb875db989bb94bc982d80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_653177e7cbf5cb1f61585d22fd0272ae |
publicationDate | 2017-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-3214443-A1 |
titleOfInvention | Rheumatoid arthritis marker |
abstract | The present invention addresses the problem of providing a method whereby disease activity of rheumatoid arthritis is evaluated reliably and with good sensitivity by a simple method, and a kit for use in the method. The present invention furthermore provides a method for accurate diagnosis of polymyalgia rheumatica and relapsing polychondritis, which are similar rheumatic diseases, a method for differentiating rheumatoid arthritis, and a kit for use in the same. The present invention provides a Jacalin-binding O-linked oligosaccharide epitope as a negative marker for diagnosing rheumatoid arthritis, and enables more accurate assessment of disease condition by more objectively determining disease activity of rheumatoid arthritis using the amount of variation of a value obtained by multiplying the amount of MMP-3 in the blood or the amount of bound MMP-3 and ABA, ACA, or ACG in the blood by the reciprocal of the amount of bound MMP-3 and Jacalin in the blood. Through the discovery that an LEL or STL-reactive sugar chain on MMP-3 in the blood is a sugar chain marker for diagnosing polymyalgia rheumatica and relapsing polychondritis, the present invention also provides a method for accurate diagnosis of polymyalgia rheumatica and relapsing polychondritis. The present invention furthermore provides a method for accurate diagnosis of rheumatoid arthritis capable of differentiating between similar rheumatic diseases, by measuring the ratio of the amount of LEL or STL bound on MMP-3 and the amount of Jacalin, ACG, or the like bound on MMP-3 in the blood. |
priorityDate | 2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 587.